Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.
about
Screening-based discovery ofAspergillus fumigatusplant-type chitinase inhibitorsClinical implications of interferon-γ genetic and epigenetic variantsPeripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosisPopulation-based analysis of invasive fungal infections, France, 2001-2010.Estimation of the burden of chronic and allergic pulmonary aspergillosis in India.Azole drug import into the pathogenic fungus Aspergillus fumigatus.Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experienceInvasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature reviewChronic pulmonary aspergillosis.Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.Republished: The clinical spectrum of pulmonary aspergillosis.Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach.Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndrome.Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
P2860
Q27684822-C219CC49-D18A-4F84-A013-8E4822436240Q28383437-046B1C50-7733-4BD0-BB1E-9232BD19D870Q33635247-D43F7DC7-5C0E-4835-BCE2-31E9AE0EC287Q33816423-9A3CCF44-3813-4740-8290-75E6B9ABD3E6Q34640786-FB61D745-07A6-41F6-B90D-149A1229AD8BQ35607733-465D1AC6-8A34-4DDE-880D-D2A7CB28402CQ36439193-8B0A8FA3-2589-4063-89FF-359F388C719FQ36864397-ED08B5E5-7330-4051-B81C-74976AF0E94DQ37113632-472C5AD6-CC8F-4F80-B758-FCDC44563529Q37631545-BF67D284-6956-49C0-9060-0D3DECA02820Q38168300-9E2335C9-AEC7-4AFE-A39D-646859CD8CB6Q38272463-A915BB05-B073-468F-A460-C52095016EBBQ38549796-971D0ACB-7999-44A9-8A85-6C19185FB43BQ41721041-32297E8B-1EB1-42DE-9B5C-745EA37A9330Q47130266-FF276136-CC27-4322-9205-96C471B9E1F5Q47645128-D54752DA-E4F4-4814-A864-87CC10A59588Q52971199-DF8BED3E-B096-4676-85B4-8E66FAD06C4FQ53696861-E8186886-3942-4513-B8E6-10FF939CD502
P2860
Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@en
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@nl
type
label
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@en
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@nl
prefLabel
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@en
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@nl
P2093
P2860
P356
P1476
Long-term antifungal treatment ...... osis: a longitudinal analysis.
@en
P2093
Christine Harris
Graham T Atherton
Khaled Al-Shair
Libuse Ratcliffe
Philippa J Newton
P2860
P304
P356
10.1093/CID/CIT411
P407
P577
2013-06-20T00:00:00Z